Sabra Health Care REIT, Inc.
Simbolis: SBRA
NASDAQ
13.93
USDRinkos kaina šiandien
234.1496
P/E santykis
-13.6793
PEG koeficientas
3.22B
MRK kapitalizacija
- 0.09%
DIV pajamingumas
Sabra Health Care REIT, Inc. (SBRA) Finansinės ataskaitos
Balansas
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 140.74 | 46.7 | 49.3 | 112 | ||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 411.4 | 0 | ||||||||||||||
balance-sheet.row.net-receivables | 2116.51 | 496.6 | 559.3 | 537.2 | ||||||||||||||
balance-sheet.row.inventory | 172.54 | 46.7 | 411.4 | 119.8 | ||||||||||||||
balance-sheet.row.other-current-assets | -156.64 | -46.7 | -406.8 | -115.9 | ||||||||||||||
balance-sheet.row.total-current-assets | 2273.15 | 543.3 | 613.2 | 653.1 | ||||||||||||||
balance-sheet.row.property-plant-equipment-net | 18780.81 | 4628.9 | 4959.3 | 5162.9 | ||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.intangible-assets | 139 | 30.9 | 40.1 | 54.1 | ||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 139 | 30.9 | 40.1 | 54.1 | ||||||||||||||
balance-sheet.row.long-term-investments | 684.9 | 213.6 | 135 | 96.7 | ||||||||||||||
balance-sheet.row.tax-assets | -18780.81 | -4628.9 | -4959.3 | -5162.9 | ||||||||||||||
balance-sheet.row.other-non-current-assets | 18750.3 | 4598.3 | 4959.3 | 5162.9 | ||||||||||||||
balance-sheet.row.total-non-current-assets | 19574.21 | 4842.9 | 5134.4 | 5313.6 | ||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.total-assets | 21847.35 | 5386.1 | 5747.7 | 5966.7 | ||||||||||||||
balance-sheet.row.account-payables | 121.86 | 0 | 142.3 | 143 | ||||||||||||||
balance-sheet.row.short-term-debt | 2082.36 | 196.6 | 197 | 1783.3 | ||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.long-term-debt-total | 9271.41 | 2217.5 | 2506.8 | 2394.5 | ||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||
balance-sheet.row.other-current-liab | -1467.72 | 34.8 | -197 | -1783.3 | ||||||||||||||
balance-sheet.row.total-non-current-liabilities | 9519.49 | 2352.2 | 2549 | 2444.2 | ||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.capital-lease-obligations | 145.87 | 32.5 | 42.2 | 49.7 | ||||||||||||||
balance-sheet.row.total-liab | 10256 | 2583.6 | 2691.3 | 2587.2 | ||||||||||||||
balance-sheet.row.preferred-stock | 1685.51 | 20.5 | 0 | 0 | ||||||||||||||
balance-sheet.row.common-stock | 9.25 | 2.3 | 2.3 | 2.3 | ||||||||||||||
balance-sheet.row.retained-earnings | -6494.47 | -1718.3 | -1451.9 | -1095.2 | ||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 90.31 | 1 | 19.1 | -10 | ||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 16300.75 | 4497.1 | 4487 | 4482.5 | ||||||||||||||
balance-sheet.row.total-stockholders-equity | 11591.36 | 2802.5 | 3056.4 | 3379.5 | ||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 21847.35 | 5386.1 | 5747.7 | 5966.7 | ||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.total-equity | 11591.36 | 2802.5 | 3056.4 | 3379.5 | ||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 21847.35 | - | - | - | ||||||||||||||
Total Investments | 684.9 | 213.6 | 597.4 | 96.7 | ||||||||||||||
balance-sheet.row.total-debt | 9612.77 | 2446.6 | 2703.8 | 2394.5 | ||||||||||||||
balance-sheet.row.net-debt | 9472.03 | 2399.9 | 2654.4 | 2282.5 |
Pinigų srautų ataskaita
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 13.76 | 13.8 | -77.6 | -113.3 | ||||||||||||||
cash-flows.row.depreciation-and-amortization | 183.09 | 183.1 | 187.8 | 179 | ||||||||||||||
cash-flows.row.deferred-income-tax | -25.1 | 2.7 | 0 | 227.8 | ||||||||||||||
cash-flows.row.stock-based-compensation | 7.92 | 7.9 | 7.5 | 7.9 | ||||||||||||||
cash-flows.row.change-in-working-capital | -2.73 | -2.7 | -19.7 | 22.7 | ||||||||||||||
cash-flows.row.account-receivables | -11.08 | -11.1 | -6.4 | 8.2 | ||||||||||||||
cash-flows.row.inventory | -8.43 | 11.1 | 6.4 | -8.2 | ||||||||||||||
cash-flows.row.account-payables | 8.34 | 8.3 | -13.3 | 14.5 | ||||||||||||||
cash-flows.row.other-working-capital | 17.05 | -11.1 | -6.4 | 8.2 | ||||||||||||||
cash-flows.row.other-non-cash-items | 123.64 | 96.4 | 217.8 | 32.2 | ||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 300.57 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -96.62 | 5.2 | 0 | -33.6 | ||||||||||||||
cash-flows.row.acquisitions-net | -6.67 | -5.2 | -142.9 | -7.8 | ||||||||||||||
cash-flows.row.purchases-of-investments | -73.23 | -191.1 | -8 | -9.1 | ||||||||||||||
cash-flows.row.sales-maturities-of-investments | 78.46 | 262.4 | 5.4 | 1.3 | ||||||||||||||
cash-flows.row.other-investing-activites | 201.18 | 31.3 | -70.7 | -287.1 | ||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 103.13 | 102.6 | -216.2 | -336.2 | ||||||||||||||
cash-flows.row.debt-repayment | -297.87 | -112.3 | -81.3 | -767.7 | ||||||||||||||
cash-flows.row.common-stock-issued | -1.49 | -2.7 | -4.8 | 308.7 | ||||||||||||||
cash-flows.row.common-stock-repurchased | -2.68 | -2.7 | -4.8 | -308.7 | ||||||||||||||
cash-flows.row.dividends-paid | -277.45 | -277.4 | -277.2 | -262.9 | ||||||||||||||
cash-flows.row.other-financing-activites | 169.19 | -15.2 | 206.3 | 1060.7 | ||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -410.3 | -410.3 | -161.7 | 30.1 | ||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -0.61 | -0.6 | 0.3 | 0 | ||||||||||||||
cash-flows.row.net-change-in-cash | -7.21 | -7.2 | -62 | 50.4 | ||||||||||||||
cash-flows.row.cash-at-end-of-period | 156.64 | 46.7 | 53.9 | 115.9 | ||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 163.85 | 53.9 | 115.9 | 65.5 | ||||||||||||||
cash-flows.row.operating-cash-flow | 300.57 | 301.1 | 315.7 | 356.4 | ||||||||||||||
cash-flows.row.capital-expenditure | -96.62 | 5.2 | 0 | -33.6 | ||||||||||||||
cash-flows.row.free-cash-flow | 203.95 | 306.4 | 315.7 | 322.8 |
Pajamų ataskaitos eilutė
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 648.5 | 655.8 | 624.8 | 569.5 | ||||||||||||||
income-statement-row.row.cost-of-revenue | 238.12 | 378.3 | 162.6 | 141.2 | ||||||||||||||
income-statement-row.row.gross-profit | 410.38 | 277.5 | 462.2 | 428.3 | ||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||
income-statement-row.row.selling-general-administrative | 47.47 | - | - | - | ||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||
income-statement-row.row.other-expenses | 43.2 | -42.4 | 187.9 | 182.9 | ||||||||||||||
income-statement-row.row.operating-expenses | 173.24 | 42.4 | 227.5 | 217.6 | ||||||||||||||
income-statement-row.row.cost-and-expenses | 411.36 | 420.8 | 390.1 | 358.8 | ||||||||||||||
income-statement-row.row.interest-income | 85.02 | 0 | 105.6 | 98.7 | ||||||||||||||
income-statement-row.row.interest-expense | 128.56 | 134.4 | 105.5 | 98.6 | ||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||
income-statement-row.row.total-other-income-expensenet | -164.4 | -227.2 | -211.9 | -130.5 | ||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||
income-statement-row.row.other-operating-expenses | 43.2 | -42.4 | 187.9 | 182.9 | ||||||||||||||
income-statement-row.row.total-operating-expenses | -164.4 | -227.2 | -211.9 | -130.5 | ||||||||||||||
income-statement-row.row.interest-expense | 128.56 | 134.4 | 105.5 | 98.6 | ||||||||||||||
income-statement-row.row.depreciation-and-amortization | 183.09 | 183.1 | 187.8 | 179 | ||||||||||||||
income-statement-row.row.ebitda-caps | 420.66 | - | - | - | ||||||||||||||
income-statement-row.row.operating-income | 326.36 | 235.1 | 135.6 | 19 | ||||||||||||||
income-statement-row.row.income-before-tax | 15.76 | 7.8 | -76.4 | -111.4 | ||||||||||||||
income-statement-row.row.income-tax-expense | 2 | 2 | 1.2 | 1.8 | ||||||||||||||
income-statement-row.row.net-income | 13.76 | 13.8 | -77.6 | -113.3 |
Dažnai užduodami klausimai
Kas yra Sabra Health Care REIT, Inc. (SBRA) bendras turtas?
Sabra Health Care REIT, Inc. (SBRA) bendras turtas yra 5386150000.000.
Kokios yra įmonės metinės pajamos?
Metinės pajamos yra 326008000.000.
Kokia yra įmonės pelno marža?
Įmonės pelno marža yra 0.633.
Koks yra įmonės laisvųjų pinigų srautas?
Laisvųjų pinigų srautas yra 0.882.
Kokia yra įmonės grynojo pelno marža?
Grynojo pelno marža yra 0.021.
Kokios yra bendros įmonės pajamos?
Bendrosios pajamos yra 0.503.
Kas yra Sabra Health Care REIT, Inc. (SBRA) grynasis pelnas (grynosios pajamos)?
Grynasis pelnas (grynosios pajamos) yra 13756000.000.
Kokia yra bendra įmonės skola?
Bendra skola yra 2446635000.000.
Koks yra veiklos sąnaudų skaičius?
Veiklos sąnaudos yra 42446000.000.
Koks yra įmonės grynųjų pinigų skaičius?
Įmonės grynieji pinigai yra 46719000.000.